Patent · US Active

Methods of providing optimized drug-eluting stent assemblies

US10406006B2 · kind B2 · utility

0Cited by
147References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2016
Grant dateSep 10, 2019
Priority date
Expiry dateDec 4, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T29/49964
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods of providing a stent assembly that includes a stent jacket formed from an expansible mesh structure having apertures and that includes a fiber having a diameter of about 7 micrometers and about 40 micrometers, and an expansible stent operatively associated with the stent jacket. The method further comprises administering to the subject an active pharmaceutical ingredient (API) eluted from the stent assembly.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.